STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer
Open Access
- 12 January 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (11), 2943-2955
- https://doi.org/10.1158/0008-5472.can-20-2874
Abstract
Pancreatic ductal adenocarcinoma (PDAC) displays a dismal prognosis due to late diagnosis and high chemoresistance incidence. For advanced disease stages or patients with comorbidities, treatment options are limited to gemcitabine alone or in combination with other drugs. While gemcitabine resistance has been widely attributed to the levels of one of its targets, RRM1, the molecular consequences of gemcitabine resistance in PDAC remain largely elusive. Here we sought to identify genomic, epigenomic, and transcriptomic events associated with gemcitabine resistance in PDAC and their potential clinical relevance. We found that gemcitabine-resistant cells displayed a coamplification of the adjacent RRM1 and STIM1 genes. Interestingly, RRM1, but not STIM1, was required for gemcitabine resistance, while high STIM1 levels caused an increase in cytosolic calcium concentration. Higher STIM1-dependent calcium influx led to an impaired endoplasmic reticulum stress response and a heightened nuclear factor of activated T-cell activity. Importantly, these findings were confirmed in patient and patient-derived xenograft samples. Taken together, our study uncovers previously unknown biologically relevant molecular properties of gemcitabine-resistant tumors, revealing an undescribed function of STIM1 as a rheostat directing the effects of calcium signaling and controlling epigenetic cell fate determination. It further reveals the potential benefit of targeting STIM1-controlled calcium signaling and its downstream effectors in PDAC. Gemcitabine-resistant and some naïve tumors coamplify RRM1 and STIM1, which elicit gemcitabine resistance and induce a calcium signaling shift, promoting ER stress resistance and activation of NFAT signaling.Other Versions
Funding Information
- German Cancer Aid (70112505)
- German Research Association (SFB1190, SFB1027)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK07198)
- NCI (CA 102701)
This publication has 58 references indexed in Scilit:
- STIM proteins: dynamic calcium signal transducersNature Reviews Molecular Cell Biology, 2012
- Restricted Heterochromatin Formation Links NFATc2 Repressor Activity With Growth Promotion in Pancreatic CancerGastroenterology, 2012
- Selective Activation of the Transcription Factor NFAT1 by Calcium Microdomains near Ca2+ Release-activated Ca2+ (CRAC) ChannelsOnline Journal of Public Health Informatics, 2011
- EGF-induced Grb7 Recruits and Promotes Ras Activity Essential for the Tumorigenicity of Sk-Br3 Breast Cancer CellsOnline Journal of Public Health Informatics, 2010
- Sequential Activation of NFAT and c-Myc Transcription Factors Mediates the TGF-β Switch from a Suppressor to a Promoter of Cancer Cell ProliferationOnline Journal of Public Health Informatics, 2010
- A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykBritish Journal of Cancer, 2010
- NFAT-Induced Histone Acetylation Relay Switch Promotes c-Myc-Dependent Growth in Pancreatic Cancer CellsGastroenterology, 2010
- Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsBritish Journal of Cancer, 2007
- Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathwayThe EMBO Journal, 2006
- ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growthThe EMBO Journal, 2005